U.S., May 14 -- An application to own the trademark for 'NEOCINE' has been filed on Sep. 30, 2024.
Owner(s):
NeoCine Therapeutics Inc.; 1521 Concord Pike, Suite 1201, , Delaware
Goods and/or Services:
For: Pharmaceutical preparations for the treatment and prevention of cancer; biological preparations for medical use in the treatment of cancer; immunotherapeutic pharmaceutical products and personalized vaccines designed to treat cancer by targeting specific neoepitopes that control tumors in vivo; anti-cancer drugs; therapeutic vaccines; diagnostic preparations for medical purposes, including those used to identify neoepitopes associated with tumor control
Class(es): 005, 006, 018, 044, 046, 051, 052
For: Downloadable computer software...